EGFR and neoplasm: In comparison with previous reports of EGFR imaging agents [22, 25, 26, 34, 35], the results of our in vivo PET imaging studies with morpholino-[124I]IPQA in mice bearing four tumor xenografts expressing different levels of phosphorylated EGFR are more selective.